Effect of Letrozole in Medical Abortio
Phase 3
Recruiting
- Conditions
- medical abortion.
- Registration Number
- IRCT20220522054961N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Any Pregnant Women
with Gestational Age Less than 14 Weeks
Candidate for Medical Abortion
with No Serious Comorbidities
No Recent or Recurrent Use of Corticosteroids
No History of and Allergy to Letrozol
No History of and Allergy to Misoprostol
Hemoglobin more than 10
Normal Coagulation and Complete blood count (CBC) test
Exclusion Criteria
Recurrent Abortion with Gestational Age Less than 14 weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Complete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Incomplete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Incomplete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Amount of Vaginal Bleeding. Timepoint: 6 Hours Before and 6 Hours After Disposal of Pregnancy Products. Method of measurement: Number of Pads Used in an our.;Surgical Curettage Rate. Timepoint: When Incomplete Abortion Occur after Receiving One Course of Misoprostol based on FIGO Protocol. Method of measurement: The Number of Patients who Underwent Surgical Curettage.
- Secondary Outcome Measures
Name Time Method